What is optic atrophy? Learn how Magnovision therapy reactivates visual pathways, who can benefit, and how this non-invasive treatment works.
Learn More
In many eye conditions—especially those affecting the retina and macula—conventional medical treatments may reach a limit. Even when disease progression is controlled, a key challenge often remains: reduced visual quality.
This is where a different paradigm emerges:
not restoring vision, but retraining how to use it.
Biofeedback and microperimetry-based vision rehabilitation focus on maximizing the use of existing vision rather than repairing damaged tissue. For patients who have not achieved sufficient benefit from traditional treatments, this approach opens a new path forward.
Biofeedback is a technique that helps individuals gain awareness and control over their biological functions to improve performance.
In ophthalmology, biofeedback is used to:
At its core lies a powerful concept: neuroplasticity.
Neuroplasticity refers to the brain’s ability to reorganize itself and form new neural connections.
When vision is impaired, the visual system does not simply “shut down.” Instead:
Biofeedback therapy actively stimulates this adaptive mechanism.
Microperimetry is an advanced diagnostic and monitoring tool that measures visual function directly on the retina.
It allows clinicians to:
Its key advantage is that it evaluates not just how much vision remains, but how effectively it is used.
Microperimetry identifies the best-performing retinal areas. Biofeedback then trains the patient to use these areas more efficiently.
The process typically involves:
Over time, patients may:
Biofeedback therapy is completely non-invasive and patient-friendly.
Typical protocol:
During sessions:
The process is painless and highly comfortable.
This therapy is particularly beneficial for patients with:
It is especially valuable in cases involving central vision loss.
The goal of biofeedback is not to restore vision completely, but to use existing vision more effectively.
Patients may experience:
These improvements directly enhance quality of life.
Recent studies show that microperimetry-guided biofeedback therapy can:
As a result, this method is increasingly included in advanced vision rehabilitation protocols worldwide.
Vision rehabilitation is an emerging and rapidly growing segment in health tourism.
For international patients, key advantages include:
These factors make it an attractive option, especially for patients from Europe seeking efficient and innovative care.
Since biofeedback is a training-based therapy, improvements develop gradually.
Patients typically:
In some cases, treatment cycles may be repeated to reinforce outcomes.
Traditional medicine often focuses on stopping disease progression.
Biofeedback, however:
This makes it a powerful option, especially in cases where patients are told there are “no further treatment options.”
For many patients, the most difficult sentence to hear is:
“There’s nothing more we can do.”
Modern vision rehabilitation challenges this notion.
Even if vision cannot be fully restored, it can often be significantly optimized.
Biofeedback and microperimetry-based rehabilitation represent one of the strongest examples of this shift—offering not just treatment, but a renewed level of independence and quality of life, especially within the scope of global health tourism.
No. The goal of this therapy is not to fully restore vision, but to teach patients how to use their existing visual capacity in the most efficient way. However, many patients experience meaningful improvements in visual performance.
No. Biofeedback is completely non-invasive and painless. During sessions, the patient simply performs visual focusing exercises.
This varies depending on the patient’s condition. Typically, programs last a few weeks with several sessions per week. Treatment is planned individually.
Some patients gain awareness after the first few sessions. Improvements in visual performance usually develop gradually over time.
It is suitable for patients with macular degeneration, Stargardt disease, retinitis pigmentosa, and central vision loss. Suitability should always be determined through a detailed evaluation.
What is optic atrophy? Learn how Magnovision therapy reactivates visual pathways, who can benefit, and how this non-invasive treatment works.
Learn More
What is Valeda light therapy for dry AMD? Learn how photobiomodulation supports vision and who may benefit from this innovative treatment.
Learn MoreFill out the form for appointments, information requests, and consultations, or contact us directly.